Nantahala Capital Management, LLC
SEC insider (Form 3/4/5 filer). CIK 0001472322. 10% Owner at TALPHERA, INC. (TLPH) and 3 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 13, 2026. Located in NEW CANAAN, CT.
Companies Nantahala Capital Management, LLC has filed insider reports for
- TALPHERA, INC. (TLPH): 10% Owner
- Evoke Pharma Inc (EVOK): 10% Owner
- AYTU BIOPHARMA, INC (AYTU): 10% Owner
- Xtant Medical Holdings, Inc. (XTNT): 10% Owner
Nantahala Capital Management, LLC
CIK: 0001472322
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 13, 2026TLPH
TALPHERA, INC.
AwardIndirectPre-Funded Warrants
4.3M shares at avg. $0.58- - Dec 17, 2025EVOK
Evoke Pharma Inc
OtherIndirect148.2K shares at avg. $11.00$1.6M - Jun 6, 2025AYTU
AYTU BIOPHARMA, INC
PurchaseIndirectPrefunded Warrants
4M shares at avg. $1.50- - Mar 31, 2025TLPH
TALPHERA, INC.
AwardIndirectPre-Funded Warrants
4.3M shares at avg. $0.58- - Jan 28, 2025EVOK
Evoke Pharma Inc
SaleIndirect41 shares at avg. $4.39$179.871
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 13, 2026 |  TLPH TALPHERA, INC. | Award Pre-Funded Warrants | 4,266,211 | $0.58 | - | Indirect |
| Dec 17, 2025 |  EVOK Evoke Pharma Inc | Other | 148,153 | $11.00 | $1,629,683 | Indirect |
| Jun 6, 2025 |  AYTU AYTU BIOPHARMA, INC | Purchase Prefunded Warrants | 4,000,000 | $1.50 | - | Indirect |
| Mar 31, 2025 | TLPH TALPHERA, INC. | Award Pre-Funded Warrants | 4,266,211 | $0.58 | - | Indirect |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | Sale | 41 | $4.39 | $180 | Indirect |
1-5 of 5 transactions